Diagnostic accuracy of IgA anti-tissue transglutaminase antibody testing in celiac disease

Contemporary guidelines for the first-line diagnosis of celiac disease recommend determination of IgA anti-tissue transglutaminase antibodies or IgA antiendomysial antibodies, as well as total serum IgA antibodies. The aim of our study was to assess the validity and clinical significance of serologi...

Full description

Bibliographic Details
Main Authors: Eremić Nevena, Đerić Mirjana, Hadnađev Ljiljana
Format: Article
Language:English
Published: Society of Medical Biochemists of Serbia, Belgrade 2012-01-01
Series:Journal of Medical Biochemistry
Subjects:
Online Access:https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2012/1452-82581202100E.pdf
_version_ 1818410064929619968
author Eremić Nevena
Đerić Mirjana
Hadnađev Ljiljana
author_facet Eremić Nevena
Đerić Mirjana
Hadnađev Ljiljana
author_sort Eremić Nevena
collection DOAJ
description Contemporary guidelines for the first-line diagnosis of celiac disease recommend determination of IgA anti-tissue transglutaminase antibodies or IgA antiendomysial antibodies, as well as total serum IgA antibodies. The aim of our study was to assess the validity and clinical significance of serological testing for IgA anti-tissue transglutaminase antibodies in the diagnosis of celiac disease, and to investigate the presence of malabsorption symptoms in celiac patients. IgA anti-tissue transglutaminase antibody testing was performed in 50 subjects with clinically suspected celiac disease (21 men and 29 women). All subjects underwent endoscopy with small intestine biopsy. Celiac disease was confirmed by histopathological findings in four subjects, whereas the IgA anti-tissue transglutaminase test was positive in three subjects. The IgA anti-tissue transglutaminase test showed sensitivity of 75% and specificity of 100%. There were significant differences between men with biopsy-confirmed and excluded celiac disease in the erythrocyte parameters MCV (96.5±7.7 vs. 78.6 ±11.3; p<0.05), MCH (36.9±4.6 vs. 25.9±4.9; p<0.01), and MCHC (382.5 ±16.3 vs. 326.9±19.1; p<0.005), as well as in the levels of total protein (47.5 ±16.3 vs. 68.3 ± 7.6; p<0.01) and albumins (24.6±9.5 vs. 42.1 ± 6.9; p<0.01). In addition, HDL-cholesterol levels were significantly lower in men with biopsy-confirmed celiac disease (0.42.±0.12 vs. 0.90± 0.30; p<0.05). Our results show a high correlation between IgA anti-tissue transglutaminase testing and endoscopy with biopsy as the gold diagnostic standard.
first_indexed 2024-12-14T10:09:35Z
format Article
id doaj.art-bc0ef2cc623145d48ed6acfd330e941e
institution Directory Open Access Journal
issn 1452-8258
1452-8266
language English
last_indexed 2024-12-14T10:09:35Z
publishDate 2012-01-01
publisher Society of Medical Biochemists of Serbia, Belgrade
record_format Article
series Journal of Medical Biochemistry
spelling doaj.art-bc0ef2cc623145d48ed6acfd330e941e2022-12-21T23:07:02ZengSociety of Medical Biochemists of Serbia, BelgradeJournal of Medical Biochemistry1452-82581452-82662012-01-013121001061452-82581202100EDiagnostic accuracy of IgA anti-tissue transglutaminase antibody testing in celiac diseaseEremić Nevena0Đerić Mirjana1Hadnađev Ljiljana2Center for Laboratory Medicine, Clinical Center of Vojvodina, Novi SadCenter for Laboratory Medicine, Clinical Center of Vojvodina, Novi SadGastroenterology and Hepatology Clinic, Clinical Center of Vojvodina, Novi SadContemporary guidelines for the first-line diagnosis of celiac disease recommend determination of IgA anti-tissue transglutaminase antibodies or IgA antiendomysial antibodies, as well as total serum IgA antibodies. The aim of our study was to assess the validity and clinical significance of serological testing for IgA anti-tissue transglutaminase antibodies in the diagnosis of celiac disease, and to investigate the presence of malabsorption symptoms in celiac patients. IgA anti-tissue transglutaminase antibody testing was performed in 50 subjects with clinically suspected celiac disease (21 men and 29 women). All subjects underwent endoscopy with small intestine biopsy. Celiac disease was confirmed by histopathological findings in four subjects, whereas the IgA anti-tissue transglutaminase test was positive in three subjects. The IgA anti-tissue transglutaminase test showed sensitivity of 75% and specificity of 100%. There were significant differences between men with biopsy-confirmed and excluded celiac disease in the erythrocyte parameters MCV (96.5±7.7 vs. 78.6 ±11.3; p<0.05), MCH (36.9±4.6 vs. 25.9±4.9; p<0.01), and MCHC (382.5 ±16.3 vs. 326.9±19.1; p<0.005), as well as in the levels of total protein (47.5 ±16.3 vs. 68.3 ± 7.6; p<0.01) and albumins (24.6±9.5 vs. 42.1 ± 6.9; p<0.01). In addition, HDL-cholesterol levels were significantly lower in men with biopsy-confirmed celiac disease (0.42.±0.12 vs. 0.90± 0.30; p<0.05). Our results show a high correlation between IgA anti-tissue transglutaminase testing and endoscopy with biopsy as the gold diagnostic standard.https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2012/1452-82581202100E.pdfceliac diseasetissue transglutaminaseantibodiesiga
spellingShingle Eremić Nevena
Đerić Mirjana
Hadnađev Ljiljana
Diagnostic accuracy of IgA anti-tissue transglutaminase antibody testing in celiac disease
Journal of Medical Biochemistry
celiac disease
tissue transglutaminase
antibodies
iga
title Diagnostic accuracy of IgA anti-tissue transglutaminase antibody testing in celiac disease
title_full Diagnostic accuracy of IgA anti-tissue transglutaminase antibody testing in celiac disease
title_fullStr Diagnostic accuracy of IgA anti-tissue transglutaminase antibody testing in celiac disease
title_full_unstemmed Diagnostic accuracy of IgA anti-tissue transglutaminase antibody testing in celiac disease
title_short Diagnostic accuracy of IgA anti-tissue transglutaminase antibody testing in celiac disease
title_sort diagnostic accuracy of iga anti tissue transglutaminase antibody testing in celiac disease
topic celiac disease
tissue transglutaminase
antibodies
iga
url https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2012/1452-82581202100E.pdf
work_keys_str_mv AT eremicnevena diagnosticaccuracyofigaantitissuetransglutaminaseantibodytestinginceliacdisease
AT đericmirjana diagnosticaccuracyofigaantitissuetransglutaminaseantibodytestinginceliacdisease
AT hadnađevljiljana diagnosticaccuracyofigaantitissuetransglutaminaseantibodytestinginceliacdisease